Docetaxel vs non‐docetaxel‐containing regimens
Progression‐free survival (PSF) · people with advanced gastric cancer
It is very uncertain whether docetaxel changes progression‐free survival ‐ Substitutive comparisons compared with non‐docetaxel‐containing regimens (very low certainty).
1 finding from 1 review
- HR 1.15 [0.77, 1.72]1 study · 119 participantsVery low